Cidara Therapeutics, Inc. at Cantor Fitzgerald Global Healthcare Conference

Event Details

Monday, 10/01/18 at 9:30 AM EDT

Webcast Presentation

Click here for webcast

Event Details

Title

Cidara Therapeutics, Inc. at Cantor Fitzgerald Global Healthcare Conference

Date / Time

Monday, 10/01/18 at 9:30 AM EDT

NAVIGATION

Overview
Financials
- SEC Filings
Stock Information
Corporate Governance
News & Events
Analyst Coverage
Shareholder Services

Tool Kit

	Print Page
	RSS Feeds
	E-mail Alerts

Get Important News and Updates by Email Subscribe

About Cidara

Cidara is a clinical-stage biotechnology company focused on developing new anti-infectives and immunotherapies that have the potential to transform the standard of care and save or improve patients' lives.
Learn more >>

Recent News

Cidara Therapeutics Announces Rezafungin Presentations at the 2019 Transplantation and Cellular Therapy (TCT) Meeting

February 5, 2019

Cidara Therapeutics Appoints James Levine as CFO and Jessica Oien as General Counsel and Secretary

December 3, 2018

Cidara Therapeutics to Present New Data at ASH 2018 Highlighting Potential of Rezafungin to Prevent Invasive Fungal Infections in Bone Marrow Transplant Patients

November 27, 2018

Navigation

Secondary Investor Relations

Overview
Presentations
Financials
Stock Information
Corporate Governance
News & Events
Analyst Coverage
Shareholder Services

Contact Us

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
Tel: (858) 752-6170
Email: info@cidara.com

Quick Links

Secondary Investor Relations

Overview
Presentations
Financials
Stock Information
Corporate Governance
News & Events
Analyst Coverage
Shareholder Services

Tweets by @CidaraThera